• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种减轻 Elecsys HIV combi PT 检测假阳性结果的方法。

A method to alleviate false-positive results of the Elecsys HIV combi PT assay.

机构信息

Department of Laboratory Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.

College of Laboratory Medicine, North Sichuan Medical College, Nanchong, Sichuan, People's Republic of China.

出版信息

Sci Rep. 2021 Jan 13;11(1):1033. doi: 10.1038/s41598-020-80047-0.

DOI:10.1038/s41598-020-80047-0
PMID:33441741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807026/
Abstract

To explore the effects of urea dissociation on reducing false-positive results of  the Elecsys HIV combi PT assay. A retrospective analysis was used to evaluate the false-positive rate of the Elecsys HIV combi PT assay. Six false-positive sera, six positive sera and six sera from patients with early HIV infection were collected. Dissociation was performed using 1 mol/L, 2 mol/L, 4 mol/L, 6 mol/L, or 8 mol/L urea, and HIV screening assay were then detected to select the appropriate concentration of urea dissociation. Next, 55 false-positive sera and 15 sera from early HIV infection were used to verify the best concentration of urea to achieve dissociation. Retrospective analysis showed that the COI of the Elecsys HIV combi PT assay in false-positive sera ranged from 1.0 to 200.0, and approximately 97.01%(227/234) of false-positive sera were in the range of 1.0-15.0. The avidity index (AI) in positive and false-positive sera decreased as the urea dissociation concentration increased. When the dissociation concentration was 6 mol/L, the AI of false-positive serum was between 0.0234 and 0.2567, and the AI of early HIV infection sera was between 0.4325 and 0.5017. The difference in AI between false-positive and positive samples was significant. When negativity was defined as an AI of less than 0.3970, the sensitivity and specificity were 100.0% and 100.0%, respectively. Urea-mediated dissociation could significantly reduce the false-positive rate of the Elecsys HIV combi PT assay with a low COI. Our findings provided a reference for distinguishing positive and false-positive of the Elecsys HIV combi PT assay.

摘要

探讨尿素解离对降低 Elecsys HIV combi PT 检测假阳性结果的影响。采用回顾性分析评估 Elecsys HIV combi PT 检测的假阳性率。收集 6 份假阳性血清、6 份阳性血清和 6 份早期 HIV 感染患者血清。用 1mol/L、2mol/L、4mol/L、6mol/L 或 8mol/L 尿素进行解离,然后检测 HIV 筛选检测以选择合适的尿素解离浓度。接下来,用 55 份假阳性血清和 15 份早期 HIV 感染血清验证尿素解离的最佳浓度。回顾性分析显示,Elecsys HIV combi PT 检测在假阳性血清中的 COI 范围为 1.0 至 200.0,约 97.01%(227/234)的假阳性血清处于 1.0-15.0 范围内。阳性和假阳性血清的亲和力指数(AI)随着尿素解离浓度的增加而降低。当解离浓度为 6mol/L 时,假阳性血清的 AI 介于 0.0234 至 0.2567 之间,早期 HIV 感染血清的 AI 介于 0.4325 至 0.5017 之间。假阳性和阳性样本之间的 AI 差异有统计学意义。当将 AI 小于 0.3970 定义为阴性时,其灵敏度和特异性分别为 100.0%和 100.0%。尿素介导的解离可显著降低 Elecsys HIV combi PT 检测的低 COI 假阳性率。我们的研究结果为区分 Elecsys HIV combi PT 检测的阳性和假阳性结果提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/a1808f8841d6/41598_2020_80047_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/be8eac194538/41598_2020_80047_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/62905d457a6f/41598_2020_80047_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/39aea087e8dc/41598_2020_80047_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/c071c6554394/41598_2020_80047_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/d353fdfd4f0e/41598_2020_80047_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/a1808f8841d6/41598_2020_80047_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/be8eac194538/41598_2020_80047_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/62905d457a6f/41598_2020_80047_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/39aea087e8dc/41598_2020_80047_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/c071c6554394/41598_2020_80047_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/d353fdfd4f0e/41598_2020_80047_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8f/7807026/a1808f8841d6/41598_2020_80047_Fig6_HTML.jpg

相似文献

1
A method to alleviate false-positive results of the Elecsys HIV combi PT assay.一种减轻 Elecsys HIV combi PT 检测假阳性结果的方法。
Sci Rep. 2021 Jan 13;11(1):1033. doi: 10.1038/s41598-020-80047-0.
2
The evaluation of low cut-off index values of Elecsys HIV combi PT assay in predicting false-positive results.Elecsys HIV combi PT 检测低值截断指数评估对预测假阳性结果的影响。
J Clin Lab Anal. 2020 Nov;34(11):e23503. doi: 10.1002/jcla.23503. Epub 2020 Aug 25.
3
Using Elecsys® HIV Combi PT assay to identify acute and early HIV infection in a teaching hospital of southwest China.在中国西南部一家教学医院使用电化学发光免疫分析法(Elecsys® HIV Combi PT assay)来识别急性和早期HIV感染。
Int J STD AIDS. 2016 Mar;27(3):213-8. doi: 10.1177/0956462415579589. Epub 2015 Mar 29.
4
Clinical application evaluation of two fourth-generation human immunodeficiency virus (HIV) screening assays in West China Hospital.两种第四代人类免疫缺陷病毒(HIV)筛查检测方法在华西医院的临床应用评估
J Clin Lab Anal. 2015 Mar;29(2):146-52. doi: 10.1002/jcla.21743. Epub 2014 May 5.
5
Validation of the Elecsys® HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia.Elecsys® HIV combi PT assay 在亚洲用于筛查和可靠的早期 HIV-1 感染检测的验证。
J Clin Virol. 2013 Sep;58(1):221-6. doi: 10.1016/j.jcv.2013.05.012. Epub 2013 Jun 26.
6
Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay.新型第四代HIV抗原/抗体联合电化学发光免疫分析法的性能评估——一种新型HIV检测法的评估
Int J STD AIDS. 2014 Mar;25(4):267-72. doi: 10.1177/0956462413499909. Epub 2013 Aug 5.
7
A retrospective analysis of the application of the Elecsys HIV combi PT assay in southern China.中国南方地区Elecsys HIV联合检测法应用的回顾性分析
J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22287. Epub 2017 Jun 26.
8
Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.新型第四代HIV筛查检测法Elecsys HIV combi的多中心评估
Clin Lab. 2006;52(9-10):463-73.
9
Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.同时检测 HIV-1 p24 抗原和 HIV-1 和 -2 抗体的两种 HIV 筛查试验的特异性。
J Virol Methods. 2017 Nov;249:143-146. doi: 10.1016/j.jviromet.2017.09.005. Epub 2017 Sep 8.
10
Clinical Application Evaluation of a Fourth-Generation HIV Antigen Antibody Combination Screening Assay.第四代HIV抗原抗体联合筛查检测的临床应用评估
Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.190220.

引用本文的文献

1
Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays.免疫功能低下癌症患者中戊型肝炎的血清学一致性较低:三种抗戊型肝炎病毒检测方法的比较研究
Antibodies (Basel). 2025 Mar 24;14(2):27. doi: 10.3390/antib14020027.
2
Evaluation of a two-test strategy for HIV screening in a low-prevalence setting and the indications for optimizing clinical management.在低流行率环境中对HIV筛查的双检测策略及优化临床管理指征的评估。
Heliyon. 2023 Aug 23;9(9):e19400. doi: 10.1016/j.heliyon.2023.e19400. eCollection 2023 Sep.
3
Data on the Relationships of Signal-To-Cutoff Ratios of Elecsys HIV Antigen/Antibody and Elecsys Syphilis Assays to Subsequent Confirmatory Testing at an Academic Medical Center.

本文引用的文献

1
Differences among diagnostic testing algorithms in the time from HIV diagnosis to care.从 HIV 诊断到治疗的时间,不同诊断检测算法之间的差异。
J Clin Virol. 2019 Jul;116:18-22. doi: 10.1016/j.jcv.2019.04.004. Epub 2019 Apr 21.
2
BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.伯乐 BioPlex® HIV Ag-Ab 检测:在低流行人群中假阳性的发生率及其对当前 HIV 检测算法的影响。
J Clin Virol. 2019 Jul;116:1-3. doi: 10.1016/j.jcv.2019.04.002. Epub 2019 Apr 6.
3
Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA.
某学术医疗中心关于Elecsys HIV抗原/抗体和Elecsys梅毒检测的信号-截断值比率与后续确证检测关系的数据。
Data Brief. 2021 Nov 6;39:107549. doi: 10.1016/j.dib.2021.107549. eCollection 2021 Dec.
尿素介导的解离可减轻 ELISA 检测到的假阳性梅毒螺旋体特异性抗体。
PLoS One. 2019 Mar 5;14(3):e0212893. doi: 10.1371/journal.pone.0212893. eCollection 2019.
4
Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.格鲁吉亚初治失败的 HIV 感染者中 HIV 耐药性的流行病学研究。
J Med Virol. 2019 Feb;91(2):235-240. doi: 10.1002/jmv.25245. Epub 2018 Oct 17.
5
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.比较第四代和第五代组合 HIV 抗原-抗体、p24 抗原和病毒载量检测方法对不同 HIV 分离株的检测限。
J Clin Microbiol. 2018 Jul 26;56(8). doi: 10.1128/JCM.02045-17. Print 2018 Aug.
6
Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.在低流行地区评估 Architect HIV Ag/Ab Combo 检测试剂:低 S/CO 比值样本的作用。
J Clin Virol. 2018 Jun;103:43-47. doi: 10.1016/j.jcv.2018.04.002. Epub 2018 Apr 4.
7
Factors associated with a second deferral among donors eligible for re-entry after a false-positive screening test for syphilis, HCV, HBV and HIV.梅毒、丙肝、乙肝和艾滋病毒假阳性筛查试验后符合重新献血条件的献血者再次延期献血的相关因素。
Vox Sang. 2018 May;113(4):339-344. doi: 10.1111/vox.12644. Epub 2018 Mar 6.
8
Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection.STAT-VIEW 快速自检的敏感性及其在急性 HIV 感染期间使用的意义。
Sex Transm Infect. 2018 Nov;94(7):475-478. doi: 10.1136/sextrans-2017-053131. Epub 2017 Aug 23.
9
The characteristics of screening and confirmatory test results for HIV in Xi'an, China.中国西安HIV筛查与确证检测结果的特征
PLoS One. 2017 Jul 7;12(7):e0180071. doi: 10.1371/journal.pone.0180071. eCollection 2017.
10
[Features and influencing factors of self-discrimination among HIV/AIDS patients according to sex].[按性别划分的艾滋病病毒/艾滋病患者自我歧视的特征及影响因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Oct 6;50(10):863-868. doi: 10.3760/cma.j.issn.0253-9624.2016.10.006.